Cold Stocks You're Selling Now

Welcome back to another Foolish review of the coldest stocks, as ranked by Motley Fool CAPS. We're looking at the three worst-performing industries over the past 30 days, and picking out your favorite short and long candidates in each.

Last week, bio-pharmaceuticals led the laggards. But not this week. This time, subprime lenders are falling faster than the ratings for NBC's Studio 60 on the Sunset Strip. Stocks of the bottom-tier bankers, as a group, are down -- wait for it -- 42.3% over the last 30 days.

Who are the other lovable losers? Have a look:

  • Falling to second are the biopharmaceuticals. Investors have inoculated their portfolios from stocks like Cadence Pharmaceuticals (Nasdaq: CADX  ) , which, as a group, are down 12.8% over the past 30 days.
  • Third worst are those stocks that -- get this -- have ticker symbols that are also the name of a country, such as the Liberty All-Star Equity Fund (NYSE: USA  ) . Stocks of these patriotic paragons, as a group, are down 12.1% over the past 30 days.

According to you, our Foolish readers, the worst stocks in these industries to own now -- i.e., those rated one or two out of a maximum five stars in CAPS -- are:

Company

CAPS Stars

No. of CAPS Ratings

Bearish CAPS Ratings

Bear Ratio

Herzfeld Caribbean Fund (Nasdaq: CUBA  )

*

104

86

82.7%

Accredited Home Lenders (Nasdaq: LEND  )

*

167

82

49.1%

New Century Financial (NYSE: NEW  )

*

329

131

39.8%

Novastar Financial (NYSE: NFI  )

*

309

90

29.1%

Source: Motley Fool CAPS

And your favorite long candidates -- i.e., those rated four or five stars in CAPS -- are:

Company

CAPS Stars

No. of CAPS Ratings

Bullish CAPS Ratings

Bull Ratio

Replidyne

****

18

13

72.2%

CDC Corp. (Nasdaq: CHINA  )

****

472

453

95.9%

Source: Motley Fool CAPS

Do you agree? Disagree? Let us know what you think by signing up for CAPS today. It's 100% free to participate.

Cap off your day with related CAPS Foolishness:

Fool contributor Tim Beyers, who is ranked 1,179 out of more than 23,600 in CAPS, is a sucker for growth stocks and a regular contributor to David Gardner's Motley Fool Rule Breakers service. Tim didn't own shares of any of the companies mentioned in this story at the time of publication. All of his portfolio holdings can be found at Tim's Fool profile. His thoughts on growth stocks, Foolishness, and investing in general may be found in his blog. The Motley Fool's disclosure policy freezes out Wall Street's worst.


Read/Post Comments (0) | Recommend This Article (33)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 523009, ~/Articles/ArticleHandler.aspx, 10/24/2014 12:36:51 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement